Xiaodong Xu Selected Research

Xiaodong Xu Research Topics

Disease

36	Neoplasms (Cancer) 05/2022 - 01/2013
28	Infections 08/2022 - 04/2009
11	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 08/2016
8	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 01/2013
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2015
5	Stomach Neoplasms (Stomach Cancer) 01/2019 - 02/2014
5	Hemolysis 11/2015 - 06/2014
4	Breast Neoplasms (Breast Cancer) 10/2020 - 01/2019
4	Colorectal Neoplasms (Colorectal Cancer) 10/2019 - 11/2013
4	Chronic Hepatitis C 06/2014 - 03/2011
3	Fibrosis (Cirrhosis) 07/2022 - 06/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2021
3	Melanoma (Melanoma, Malignant) 01/2019 - 11/2017
3	Chronic Hepatitis B 01/2017 - 09/2010
3	Diarrhea 04/2013 - 04/2009
2	Carcinogenesis 05/2022 - 02/2021
2	Acquired Immunodeficiency Syndrome (AIDS) 03/2022 - 07/2017
2	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2022 - 01/2019
2	Wounds and Injuries (Trauma) 01/2022 - 03/2018
2	Cholangiocarcinoma 01/2022 - 08/2017
2	Necrosis 04/2021 - 06/2016
2	Septic Shock (Toxic Shock Syndrome) 01/2021 - 01/2021
2	Proteinuria 01/2021 - 08/2017
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021 - 07/2014
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 07/2019 - 01/2019
2	Inflammation (Inflammations) 05/2018 - 01/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2015 - 01/2015
2	Insulin Resistance 01/2015 - 07/2014
2	Virus Diseases (Viral Diseases) 07/2014 - 08/2012
2	Coinfection 07/2014 - 01/2013
2	Viremia 11/2011 - 01/2011
1	Hemorrhage 08/2022
1	Cardiomyopathies (Cardiomyopathy) 07/2022
1	Multiple Myeloma 04/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2022
1	Membranous Glomerulonephritis (Membranous Nephropathy) 03/2022
1	Tics (Tic) 02/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Flushing 01/2022

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2013
11	Antiviral Agents (Antivirals)IBA 01/2017 - 04/2009
8	CytokinesIBA 03/2022 - 05/2013
7	Pharmaceutical PreparationsIBA 05/2022 - 03/2011
6	Biological ProductsIBA 03/2022 - 07/2012
5	Messenger RNA (mRNA)IBA 03/2022 - 07/2014
5	Long Noncoding RNAIBA 01/2022 - 08/2017
5	LipidsIBA 04/2021 - 01/2015
4	Circular RNAIBA 04/2022 - 01/2020
4	Peptides (Polypeptides)IBA 03/2022 - 01/2013
4	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2020
4	Small Interfering RNA (siRNA)IBA 07/2019 - 03/2015
4	SugarsIBA 06/2013 - 04/2009
4	GlucosidasesIBA 06/2013 - 01/2011
3	IronIBA 01/2022 - 01/2019
3	Blood Glucose (Blood Sugar)IBA 01/2021 - 07/2014
3	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 09/2010
3	LuciferasesIBA 01/2020 - 01/2019
3	tocophersolanIBA 11/2015 - 08/2014
2	Polysaccharides (Glycans)IBA 01/2022 - 12/2015
2	Histones (Histone)IBA 01/2021 - 10/2020
2	fisetinIBA 10/2020 - 01/2019
2	Sincalide FDA Link 10/2020 - 04/2017
2	FlavonoidsIBA 10/2020 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020 - 05/2018
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 06/2016
2	Carrier Proteins (Binding Protein)IBA 12/2019 - 08/2017
2	VaccinesIBA 10/2019 - 09/2014
2	Versicans (Versican)IBA 07/2019 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 07/2019 - 01/2019
2	PolymersIBA 01/2019 - 03/2015
2	Interleukin-18 (Interleukin 18)IBA 03/2018 - 12/2016
2	Antineoplastic Agents (Antineoplastics)IBA 06/2016 - 01/2015
2	Lactic Acid (Lactate)FDA LinkGeneric 11/2015 - 01/2015
2	Lipid Bilayers (Lipid Bilayer)IBA 11/2015 - 08/2014
2	AntioxidantsIBA 03/2015 - 01/2015
2	LecithinsIBA 01/2015 - 06/2014
2	AntibodiesIBA 07/2014 - 05/2013
2	Imino SugarsIBA 06/2013 - 01/2011
2	Interferon-alpha (Interferon Alfa)IBA 06/2013 - 09/2010
1	Hemostatics (Antihemorrhagics)IBA 08/2022
1	AlginatesIBA 08/2022
1	ChitosanIBA 08/2022
1	GadoliniumIBA 07/2022
1	Amyloid (Amyloid Fibrils)IBA 05/2022
1	Complement System Proteins (Complement)IBA 03/2022
1	ElectrolytesIBA 03/2022
1	Oxygen (Dioxygen)IBA 03/2022
1	SaltsIBA 03/2022
1	RNA Splice SitesIBA 02/2022
1	SilverIBA 01/2022
1	Aldehyde DehydrogenaseIBA 01/2022
1	Competitive Endogenous RNAIBA 01/2022

Therapy/Procedure

13	Therapeutics 05/2022 - 04/2009
3	Laparotomy 01/2021 - 03/2014
2	Treatment Delay 01/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 10/2020 - 10/2020
2	Radiotherapy 01/2019 - 12/2018
2	Nutritional Support (Artificial Feeding) 06/2018 - 03/2014
2	Oral Administration 01/2017 - 01/2011